{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:48Z","timestamp":1790787348526,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3609,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p>A 10\u2010year\u2010old girl with chronic myelogenous leukemia began receiving cyclosporine the day before bone marrow transplant surgery. Three days after the transplant, she developed fever and neutropenia due to a <jats:italic>Staphylococcus aureus<\/jats:italic> bacteremia. Despite treatment with various antibiotics, the patient's fever persisted over the next 4 days. Intravenous rifampin was added to her antibiotic regimen of piperacillin, tobramycin, cloxacillin, and amphotericin. On day 12, the patient's blood cultures were negative and her fever had resolved; rifampin was discontinued. On day 16, the patient engrafted; she subsequently developed a grade II graft\u2010versus\u2010host disease of the skin and gastrointestinal tract, which responded to methylprednisolone. Her cyclosporine blood levels, which had been subtherapeutic since day 5 despite increasing intravenous dosages, were within the therapeutic range on day 21, and she was discharged 12 days later. To our knowledge, this is the first documented case of an intravenous cyclosporine\u2010rifampin interaction that resulted in subtherapeutic cyclosporine concentrations in a child receiving a bone marrow transplant who subsequently developed acute graft\u2010versus\u2010host disease.<\/jats:p>","DOI":"10.1592\/phco.22.5.387.33190","type":"journal-article","created":{"date-parts":[[2004,5,21]],"date-time":"2004-05-21T09:33:50Z","timestamp":1085132030000},"page":"387-390","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intravenous Cyclosporine\u2010Rifampin Interaction in a Pediatric Bone Marrow Transplant Recipient"],"prefix":"10.1002","volume":"22","author":[{"given":"Elyse J.","family":"Zelunka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"492","volume-title":"AHFS drug information 1999","author":"McEvoy G.K.","year":"1999"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199307000-00049"},{"key":"e_1_2_1_4_2","first-page":"2823","article-title":"Drug interactions between cyclosporine and rifampicin, erythromycin, and azoles in kidney recipients with opportunistic infections","volume":"25","author":"Koselj M.","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000166968"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183583"},{"key":"e_1_2_1_7_2","first-page":"1624","article-title":"The antagonistic effect of rifampin on cyclosporine bioavailability","volume":"26","author":"Buren D.","year":"1984","journal-title":"Transplant Proc"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91019-X"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90629-9"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92845-4"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198503000-00022"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.995"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900204"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03830.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.171"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(21)00046-7"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116064"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90168-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53221-X"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6663"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90027-8"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800315"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807143190201"},{"key":"e_1_2_1_24_2","first-page":"461","article-title":"Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft\u2010versus\u2010host disease","volume":"7","author":"Przepiorka D.","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198705000-00016"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.22.5.387.33190","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.22.5.387.33190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:31Z","timestamp":1761059131000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.22.5.387.33190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1592\/phco.22.5.387.33190"],"URL":"https:\/\/doi.org\/10.1592\/phco.22.5.387.33190","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}